These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 16166447)

  • 81. Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor.
    Kumar S; Mokhtari RB; Sheikh R; Wu B; Zhang L; Xu P; Man S; Oliveira ID; Yeger H; Kerbel RS; Baruchel S
    Clin Cancer Res; 2011 Sep; 17(17):5656-67. PubMed ID: 21788355
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.
    El-Naa MM; Othman M; Younes S
    Drug Des Devel Ther; 2016; 10():3661-3672. PubMed ID: 27895461
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.
    Kieran MW; Turner CD; Rubin JB; Chi SN; Zimmerman MA; Chordas C; Klement G; Laforme A; Gordon A; Thomas A; Neuberg D; Browder T; Folkman J
    J Pediatr Hematol Oncol; 2005 Nov; 27(11):573-81. PubMed ID: 16282886
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prediction of in vivo synergistic activity of antiangiogenic compounds by gene expression profiling.
    Cline EI; Bicciato S; DiBello C; Lingen MW
    Cancer Res; 2002 Dec; 62(24):7143-8. PubMed ID: 12499246
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Antiangiogenic and apoptotic properties of a novel amphiphilic folate-heparin-lithocholate derivative having cellular internality for cancer therapy.
    Yu MK; Lee DY; Kim YS; Park K; Park SA; Son DH; Lee GY; Nam JH; Kim SY; Kim IS; Park RW; Byun Y
    Pharm Res; 2007 Apr; 24(4):705-14. PubMed ID: 17318418
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
    Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Anticancer activity of docetaxel in murine salivary gland carcinoma.
    Piechocki MP; Lonardo F; Ensley JF; Nguyen T; Kim H; Yoo GH
    Clin Cancer Res; 2002 Mar; 8(3):870-7. PubMed ID: 11895921
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The use of nanoparticulate delivery systems in metronomic chemotherapy.
    Yu DH; Ban FQ; Zhao M; Lu Q; Lovell JF; Bai F; Wang C; Guan YY; Luan X; Liu YR; Fang C; Chen HZ
    Biomaterials; 2013 May; 34(16):3925-3937. PubMed ID: 23465835
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro.
    Zhou HJ; Zhang JL; Li A; Wang Z; Lou XE
    Cancer Chemother Pharmacol; 2010 May; 66(1):21-9. PubMed ID: 19756601
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1.
    Bocci G; Fioravanti A; Orlandi P; Di Desidero T; Natale G; Fanelli G; Viacava P; Naccarato AG; Francia G; Danesi R
    Neoplasia; 2012 Sep; 14(9):833-45. PubMed ID: 23019415
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts.
    Naganuma Y; Choijamts B; Shirota K; Nakajima K; Ogata S; Miyamoto S; Kawarabayashi T; Emoto M
    Cancer Sci; 2011 Aug; 102(8):1545-52. PubMed ID: 21631643
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Modulation of the antitumor activity of metronomic cyclophosphamide by the angiogenesis inhibitor axitinib.
    Ma J; Waxman DJ
    Mol Cancer Ther; 2008 Jan; 7(1):79-89. PubMed ID: 18202011
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.
    Ren B; Song K; Parangi S; Jin T; Ye M; Humphreys R; Duquette M; Zhang X; Benhaga N; Lawler J; Khosravi-Far R
    Cancer Res; 2009 May; 69(9):3856-65. PubMed ID: 19366809
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy.
    Yue T; Zheng X; Dou Y; Zheng X; Sun R; Tian Z; Wei H
    BMC Cancer; 2016 Aug; 16(1):665. PubMed ID: 27549240
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth.
    Mirochnik Y; Aurora A; Schulze-Hoepfner FT; Deabes A; Shifrin V; Beckmann R; Polsky C; Volpert OV
    Clin Cancer Res; 2009 Mar; 15(5):1655-63. PubMed ID: 19223494
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer.
    Previs RA; Armaiz-Pena GN; Lin YG; Davis AN; Pradeep S; Dalton HJ; Hansen JM; Merritt WM; Nick AM; Langley RR; Coleman RL; Sood AK
    Mol Cancer Ther; 2015 Dec; 14(12):2677-86. PubMed ID: 26516159
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growth.
    Srivastava K; Hu J; Korn C; Savant S; Teichert M; Kapel SS; Jugold M; Besemfelder E; Thomas M; Pasparakis M; Augustin HG
    Cancer Cell; 2014 Dec; 26(6):880-895. PubMed ID: 25490450
    [TBL] [Abstract][Full Text] [Related]  

  • 98. An apoptosis-homing peptide-conjugated low molecular weight heparin-taurocholate conjugate with antitumor properties.
    Bae SM; Kim JH; Chung SW; Byun Y; Kim SY; Lee BH; Kim IS; Park RW
    Biomaterials; 2013 Mar; 34(8):2077-86. PubMed ID: 23245333
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3].
    Kang XM; Zhang QY; Tong DD; Zhao W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):730-3. PubMed ID: 16152834
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Metronomic trofosfamide inhibits progression of human lung cancer xenografts by exerting anti-angiogenic effects.
    Klink T; Bela C; Stoelting S; Peters SO; Broll R; Wagner T
    J Cancer Res Clin Oncol; 2006 Oct; 132(10):643-52. PubMed ID: 16761121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.